Literature DB >> 16892062

Decidual NK cells regulate key developmental processes at the human fetal-maternal interface.

Jacob Hanna1, Debra Goldman-Wohl, Yaron Hamani, Inbal Avraham, Caryn Greenfield, Shira Natanson-Yaron, Diana Prus, Leonor Cohen-Daniel, Tal I Arnon, Irit Manaster, Roi Gazit, Vladimir Yutkin, Daniel Benharroch, Angel Porgador, Eli Keshet, Simcha Yagel, Ofer Mandelboim.   

Abstract

Human CD56(bright) NK cells accumulate in the maternal decidua during pregnancy and are found in direct contact with fetal trophoblasts. Several mechanisms have been proposed to explain the inability of NK cells to kill the semiallogeneic fetal cells. However, the actual functions of decidual NK (dNK) cells during pregnancy are mostly unknown. Here we show that dNK cells, but not peripheral blood-derived NK subsets, regulate trophoblast invasion both in vitro and in vivo by production of the interleukin-8 and interferon-inducible protein-10 chemokines. Furthermore, dNK cells are potent secretors of an array of angiogenic factors and induce vascular growth in the decidua. Notably, such functions are regulated by specific interactions between dNK-activating and dNK-inhibitory receptors and their ligands, uniquely expressed at the fetal-maternal interface. The overall results support a 'peaceful' model for reproductive immunology, in which elements of innate immunity have been incorporated in a constructive manner to support reproductive tissue development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16892062     DOI: 10.1038/nm1452

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  523 in total

Review 1.  The role of the invasive, placental trophoblast in human pregnancy.

Authors:  Jürgen Pollheimer; Martin Knöfler
Journal:  Wien Med Wochenschr       Date:  2012-05

2.  Innate immune natural killer cells and their role in HIV and SIV infection.

Authors:  Pavel Bostik; Yoshiaki Takahashi; Ann E Mayne; Aftab A Ansari
Journal:  HIV Ther       Date:  2010-07-01

3.  Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection.

Authors:  Hailong Guo; David J Topham
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

4.  Vascular-leukocyte interactions: mechanisms of human decidual spiral artery remodeling in vitro.

Authors:  Aleah D Hazan; Samantha D Smith; Rebecca L Jones; Wendy Whittle; Stephen J Lye; Caroline E Dunk
Journal:  Am J Pathol       Date:  2010-06-17       Impact factor: 4.307

5.  Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2.

Authors:  Susan E Hiby; Richard Apps; Andrew M Sharkey; Lydia E Farrell; Lucy Gardner; Arend Mulder; Frans H Claas; James J Walker; Christopher W Redman; Christopher C Redman; Linda Morgan; Clare Tower; Lesley Regan; Gudrun E Moore; Mary Carrington; Ashley Moffett
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

6.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

7.  Non-classical MHC-E (Mamu-E) expression in the rhesus monkey placenta.

Authors:  S V Dambaeva; G I Bondarenko; R L Grendell; R H Kravitz; M Durning; T G Golos
Journal:  Placenta       Date:  2007-11-09       Impact factor: 3.481

Review 8.  Molecular Cross-Talk at the Feto-Maternal Interface.

Authors:  Gendie E Lash
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-18       Impact factor: 6.915

9.  How has the study of the human placenta aided our understanding of partially methylated genes?

Authors:  Diane I Schroeder; Janine M LaSalle
Journal:  Epigenomics       Date:  2013-12       Impact factor: 4.778

10.  IL-22 secreted by decidual stromal cells and NK cells promotes the survival of human trophoblasts.

Authors:  Ying Wang; Bing Xu; Ming-Qing Li; Da-Jin Li; Li-Ping Jin
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.